title: Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells.
abstract: C4b and C3b deposited on host cells undergo limited proteolytic cleavage by regulatory proteins. Membrane cofactor protein (MCP; CD46), factor H, and C4b binding protein mediate this reaction, known as cofactor activity, that also requires the plasma serine protease factor I. To explore the roles of the fluid phase regulators vs those expressed on host cells, a model system was used examining complement fragments deposited on cells transfected with human MCP as assessed by FACS and Western blotting. Following incubation with Ab and complement on MCP(+) cells, C4b was progressively cleaved over the first hour to C4d and C4c. There was no detectable cleavage of C4b on MCP(-) cells, indicating that MCP (and not C4BP in the serum) primarily mediates this cofactor activity. C3b deposition was not blocked on MCP(+) cells because classical pathway activation occurred before substantial C4b cleavage. Cleavage, though, of deposited C3b was rapid (<5 min) and iC3b was the dominant fragment on MCP(-) and MCP(+) cells. Studies using a function-blocking mAb further established factor H as the responsible cofactor. If the level of Ab sensitization was reduced 8-fold or if Mg(2+)-EGTA was used to block the classical pathway, MCP efficiently inhibited C3b deposition mediated by the alternative pathway. Thus, for the classical pathway, MCP is the cofactor for C4b cleavage and factor H for C3b cleavage. However, if the alternative pathway mediates C3b deposition, then MCP's cofactor activity is sufficient to restrict complement activation.
authors.affiliation: Division of Rheumatology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
authors.forename: Maria L
authors.initials: ML
authors.lastname: Barilla-LaBarca
authors.forename: M Kathryn
authors.initials: MK
authors.lastname: Liszewski
authors.forename: John D
authors.initials: JD
authors.lastname: Lambris
authors.forename: Dennis
authors.initials: D
authors.lastname: Hourcade
authors.forename: John P
authors.initials: JP
authors.lastname: Atkinson
mesh_terms: D000818:Animals; D015703:Antigens, CD / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D016466:CHO Cells / Q000276:immunology / Q000378:metabolism; D003179:Complement C3b / Q000378:metabolism*; D015935:Complement C4b / Q000378:metabolism*; D003182:Complement C5 / Q000378:metabolism; D050776:Complement C5b; D017242:Complement Factor H / Q000502:physiology; D003169:Complement Inactivator Proteins / Q000502:physiology; D003170:Complement Pathway, Alternative; D003171:Complement Pathway, Classical / Q000235:genetics; D006224:Cricetinae; D004306:Dose-Response Relationship, Immunologic; D006801:Humans; D006868:Hydrolysis; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D008565:Membrane Proteins / Q000378:metabolism; D010446:Peptide Fragments / Q000378:metabolism; D011485:Protein Binding / Q000276:immunology; D014162:Transfection
chemical_list: D015703:Antigens, CD; C497857:CD46 protein, human; C493495:CFH protein, human; D003182:Complement C5; D003169:Complement Inactivator Proteins; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins; D008565:Membrane Proteins; D010446:Peptide Fragments; D003179:Complement C3b; D015935:Complement C4b; D050776:Complement C5b; D017242:Complement Factor H